BioPoint - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,760,882 | 3,548,438 | 1,858,501 | 2,194,699 | 364,627 | 250,815 | 96,899 | 66,002 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 169,242 | -44,831 | -47,106 | 5,831 | -5,481 | 194,810 | 38,741 | -10,032 |
| Equity | 236,326 | 191,290 | 144,184 | 150,015 | 144,534 | 339,344 | 378,085 | 368,053 |
| Liabilities | 190,384 | 252,150 | 155,571 | 170,400 | 101,443 | 43,887 | 18,759 | 508,714 |
| Non-current assets | 242,651 | 192,800 | 118,171 | 80,433 | 38,897 | 118,991 | 184,930 | 634,521 |
| Current assets | 182,929 | 250,472 | 181,500 | 239,810 | 207,080 | 260,422 | 210,363 | 241,759 |
| Total assets | 425,580 | 443,272 | 299,671 | 320,243 | 245,977 | 379,413 | 395,293 | 876,280 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 9,454 | 21,992 | 7,818 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +541.3% | +28.5% | -47.6% | +18.1% | -83.4% | -31.2% | -61.4% | -31.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 39.8% | -10.1% | -15.7% | 1.8% | -2.2% | 51.3% | 9.8% | -1.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 71.6% | -23.4% | -32.7% | 3.9% | -3.8% | 57.4% | 10.2% | -2.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.1% | -1.3% | -2.5% | 0.3% | -1.5% | 77.7% | 40.0% | -15.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.8 | 1.3 | 1.1 | 1.1 | 0.7 | 0.1 | 0.0 | 1.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 974,440 | 1,216,593 | 857,756 | 1,097,350 | 364,627 | 250,815 | 96,899 | 66,002 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BioPoint - Social security debts
The company had no debts to Sodra
BioPoint - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BioPoint, UAB (company code 302418364) is a Private Limited Liability Company engaged in wholesale of motor vehicles. In the latest financial year, 2025, revenue was EUR 66.0K, down 31.9% year on year and 73.7% versus 2023. Net profit fell from EUR 194.8K in 2023 to EUR 38.7K in 2024 and then turned into a loss of EUR 10.0K in 2025. The 2025 profit margin was -15.2%, confirming a clear decline in profitability over the three-year period. At the same time, the balance sheet expanded: total assets reached EUR 876.3K in 2025, compared with EUR 395.3K in 2024 and EUR 379.4K in 2023. Equity stood at EUR 368.1K and liabilities at EUR 508.7K. Long-term assets increased to EUR 634.5K, while short-term assets were EUR 241.8K. Key ratios show moderate leverage and weak operating efficiency, with debt-to-equity at 1.38, equity ratio at 42.0%, ROE at -2.7%, ROA at -1.1% and asset turnover at 0.08x. Revenue per employee was EUR 66.0K.